% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Winter:909680,
author = {Winter, Nils R. and Leenings, Ramona and Ernsting, Jan and
Sarink, Kelvin and Fisch, Lukas and Emden, Daniel and
Blanke, Julian and Goltermann, Janik and Opel, Nils and
Barkhau, Carlotta and Meinert, Susanne and Dohm, Katharina
and Repple, Jonathan and Mauritz, Marco and Gruber, Marius
and Leehr, Elisabeth J. and Grotegerd, Dominik and Redlich,
Ronny and Jansen, Andreas and Nenadic, Igor and Nöthen,
Markus M. and Forstner, Andreas and Rietschel, Marcella and
Groß, Joachim and Bauer, Jochen and Heindel, Walter and
Andlauer, Till and Eickhoff, Simon and Kircher, Tilo and
Dannlowski, Udo and Hahn, Tim},
title = {{Q}uantifying {D}eviations of {B}rain {S}tructure and
{F}unction in {M}ajor {D}epressive {D}isorder {A}cross
{N}euroimaging {M}odalities},
journal = {JAMA psychiatry},
volume = {79},
number = {9},
issn = {0003-990X},
address = {Chicago, Ill.},
publisher = {AMA},
reportid = {FZJ-2022-03335},
pages = {879 -888},
year = {2022},
note = {Kein postprint vorhanden},
abstract = {Importance Identifying neurobiological differences between
patients with major depressive disorder (MDD) and healthy
individuals has been a mainstay of clinical neuroscience for
decades. However, recent meta-analyses have raised concerns
regarding the replicability and clinical relevance of brain
alterations in depression.Objective To quantify the upper
bounds of univariate effect sizes, estimated predictive
utility, and distributional dissimilarity of healthy
individuals and those with depression across structural
magnetic resonance imaging (MRI), diffusion-tensor imaging,
and functional task-based as well as resting-state MRI, and
to compare results with an MDD polygenic risk score (PRS)
and environmental variables.Design, Setting, and
Participants This was a cross-sectional, case-control
clinical neuroimaging study. Data were part of the
Marburg-Münster Affective Disorders Cohort Study. Patients
with depression and healthy controls were recruited from
primary care and the general population in Münster and
Marburg, Germany. Study recruitment was performed from
September 11, 2014, to September 26, 2018. The sample
comprised patients with acute and chronic MDD as well as
healthy controls in the age range of 18 to 65 years. Data
were analyzed from October 29, 2020, to April 7, 2022.Main
Outcomes and Measures Primary analyses included univariate
partial effect size (η2), classification accuracy, and
distributional overlapping coefficient for healthy
individuals and those with depression across neuroimaging
modalities, controlling for age, sex, and additional
modality-specific confounding variables. Secondary analyses
included patient subgroups for acute or chronic depressive
status.Results A total of 1809 individuals (861 patients
$[47.6\%]$ and 948 controls $[52.4\%])$ were included in the
analysis (mean [SD] age, 35.6 [13.2] years; 1165 female
patients $[64.4\%]).$ The upper bound of the effect sizes of
the single univariate measures displaying the largest group
difference ranged from partial η2 of 0.004 to 0.017, and
distributions overlapped between $87\%$ and $95\%,$ with
classification accuracies ranging between $54\%$ and $56\%$
across neuroimaging modalities. This pattern remained
virtually unchanged when considering either only patients
with acute or chronic depression. Differences were
comparable with those found for PRS but substantially
smaller than for environmental variables.Conclusions and
Relevance Results of this case-control study suggest that
even for maximum univariate biological differences,
deviations between patients with MDD and healthy controls
were remarkably small, single-participant prediction was not
possible, and similarity between study groups dominated.
Biological psychiatry should facilitate meaningful outcome
measures or predictive approaches to increase the potential
for a personalization of the clinical practice.},
cin = {INM-7 / INM-1},
ddc = {610},
cid = {I:(DE-Juel1)INM-7-20090406 / I:(DE-Juel1)INM-1-20090406},
pnm = {5251 - Multilevel Brain Organization and Variability
(POF4-525)},
pid = {G:(DE-HGF)POF4-5251},
typ = {PUB:(DE-HGF)16},
pubmed = {35895072},
UT = {WOS:000832645100001},
doi = {10.1001/jamapsychiatry.2022.1780},
url = {https://juser.fz-juelich.de/record/909680},
}